Surgery PartnersSGRY
About: Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Employees: 13,500
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
87% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 46
3.64% more ownership
Funds ownership: 108.01% [Q1] → 111.65% (+3.64%) [Q2]
1% more funds holding
Funds holding: 177 [Q1] → 179 (+2) [Q2]
6% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 31
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
17% less capital invested
Capital invested by funds: $4.08B [Q1] → $3.38B (-$703M) [Q2]
63% less call options, than puts
Call options by funds: $5.05M | Put options by funds: $13.7M
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
Cantor Fitzgerald Sarah James 46% 1-year accuracy 51 / 112 met price target | 45%upside $43 | Overweight Reiterated | 4 Oct 2024 |
Benchmark Bill Sutherland 53% 1-year accuracy 26 / 49 met price target | 68%upside $50 | Buy Reiterated | 26 Aug 2024 |
Cantor Fitzgerald Sarah James 46% 1-year accuracy 51 / 112 met price target | 45%upside $43 | Overweight Reiterated | 20 Aug 2024 |
Cantor Fitzgerald Sarah James 46% 1-year accuracy 51 / 112 met price target | 45%upside $43 | Overweight Reiterated | 19 Aug 2024 |
Citigroup Jason Cassorla 78% 1-year accuracy 7 / 9 met price target | 21%upside $36 | Buy Maintained | 7 Aug 2024 |